ULTIMED ROLLS OUT PRIVATE LABEL PROGRAM FOR INSULIN SYRINGES

ST. PAUL, MINNESOTA – March 25, 2004 – UltiMed has developed an innovative private label program which addresses the problems retailers and wholesalers have traditionally had with private label syringes. UltiMed's new program solves many of the difficulties of the past by giving retailers the tools to increase penetration rates and increase contribution margins.

UltiMed will be offering to retailers and wholesalers their new private label program for syringes in both of its packaging styles; the traditional cardboard box and the new patented dual-use UltiGuard plastic syringe dispenser/sharps container. The UltiGuard syringe dual-use packaging style conveniently packages 100 U.S. made insulin syringes within its attractive, pearlescent sharps container at a price less than the leading brand giving consumers a convenient, cost effective option for safe storage and disposal of used syringes.

UltiMed, Inc. which is headquartered in St. Paul, Minnesota markets syringes, needles, lancets and innovative dual-purpose sharps containers for both the domestic and international markets. The Company owns and operates state of the art medical device manufacturing facilities in the U.S. and abroad. UltiMed also has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world.

UltiMed Inc., 287 East 6th Street, St. Paul, MN 55101 www.ulti-care.com